| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5615707 | The Journal of Heart and Lung Transplantation | 2017 | 25 Pages |
Abstract
Angiotensin II antagonism is associated with a reduced risk of AVM-related GIB in patients with LVADs. This association is independent of age, sex, blood pressure, renal function, international normalized ratio, LVAD type, and cardiomyopathy etiology.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Brian A. MD, Andrea L.C. MD, PhD, Joban MD, David M. MD, P. Elliott MD, Kamil F. MD, Ashish MD, Chris MD, PhD, Glenn MD, Ryan J. MD, Gerin R. MD, PhD, Daniel P. MD, Stuart D. MD, Rosanne MD,